Alpine Immune Sciences (ALPN) – Investment Analysts' Recent Ratings Updates

Alpine Immune Sciences (NASDAQ: ALPN) has recently received a number of price target changes and ratings updates: 9/1/2023 – Alpine Immune Sciences had its “outperform” rating reaffirmed by analysts at Wedbush. They now have a $19.00 price target on the stock. 8/31/2023 – Alpine Immune Sciences had its “buy” rating reaffirmed by analysts at HC […]

Related Keywords

,Great Point Partners ,Vanguard Group Inc ,Alpine Immune Sciences Stock Performance ,Blackrock Inc ,Institutional Trading Of Alpine Immune Sciences ,Alpine Immune Sciences Inc ,Alpine Immune Sciences ,Immune Sciences ,Alpine Immune ,Point Partners ,Avidity Partners Management ,Partners Management ,Alpine Immune Sciences Inc Daily ,Nasdaq Alpn ,Alpn ,